SEARCH RESULTS FOR:

Mining
Peru

Engineering and Construction

Peru Mining 2018 Pre-Release
Providers eagerly await the transition from the studies and the early works to the execution of multi-billion dollar projects.
Mining
Canada

Manitoba’s Exploration Potential

Saskatchewan & Manitoba Mining 2018
Manitoba lacks advanced exploration projects, meaning a lag in traction and new mine development in the foreseeable future, but with a continued focus from the government and an uptick in mining investment, the province has all the makings for success in the longer-term.
Pharma & Life Sciences
China

Dr. Xu Jia

CONSULTING LEADER, PWC CHINA HEALTHCARE AND PHARMACEUTICALS
PwC in China is benefitting from the rise of the biopharma and a flurry of IPO and acquisition activities in the pharma industry more generally.
Mining
DRC
Ghana
Morocco
MACIG

Amaury Lescaux

MANAGING DIRECTOR, SMT
SMT has expanded its Volvo dealership within and beyond Africa.
Mining
Peru

Manuel Fumagalli

PRESIDENT, ORGANIZING COMMITTEE, 13TH INT. GOLD AND SILVER SYMPOSIUM
Peru Mining 2018 Pre-Release
This year’s International Gold and Silver Symposium, taking place on 29th of May in Peru, will focus on technology and innovation.
Mining
Canada

Patrick Soares

FORAN MINING
Saskatchewan & Manitoba Mining 2018
Foran mining continue to expand the resource bace at its McIlvenna Bay property in preparation for an upturn.
Mining
Canada

Saskatchewan & Manitoba Mining 2018

United States
Pharma & Life Sciences

Nick Grasman

LEAD MARKET MANAGER, DOW PHARMA SOLUTIONS, THE DOW CHEMICAL COMPANY
United States Biopharmaceuticals 2018
Dow Pharma Solutions develops functional excipients and APIs that enable improved pharmaceutical delivery and enhanced solubility.
Mining
Peru

Steve Dixon

CEO, STRACON
Peru Mining 2018 Pre-Release
STRACON’s CEO, Steve Dixon, provides its vision and strategy as it enters a new phase under new owners.
United States
Pharma & Life Sciences

Infectious Diseases: Addressing Growing Resistance

United States Biopharmaceuticals 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL